nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylnaltrexone—CYP2D6—Carteolol—glaucoma	0.21	0.334	CbGbCtD
Methylnaltrexone—CYP2D6—Betaxolol—glaucoma	0.142	0.226	CbGbCtD
Methylnaltrexone—CYP2D6—Methazolamide—glaucoma	0.108	0.171	CbGbCtD
Methylnaltrexone—CYP2D6—Timolol—glaucoma	0.0915	0.145	CbGbCtD
Methylnaltrexone—CYP2D6—Clonidine—glaucoma	0.0778	0.124	CbGbCtD
Methylnaltrexone—Redness—Echothiophate—glaucoma	0.0196	0.0529	CcSEcCtD
Methylnaltrexone—Stinging—Dipivefrin—glaucoma	0.0195	0.0526	CcSEcCtD
Methylnaltrexone—Stinging—Echothiophate—glaucoma	0.0163	0.044	CcSEcCtD
Methylnaltrexone—Stinging—Carbachol—glaucoma	0.00974	0.0263	CcSEcCtD
Methylnaltrexone—Stinging—Levobunolol—glaucoma	0.00959	0.0259	CcSEcCtD
Methylnaltrexone—Stinging—Latanoprost—glaucoma	0.0089	0.024	CcSEcCtD
Methylnaltrexone—Redness—Dorzolamide—glaucoma	0.007	0.0189	CcSEcCtD
Methylnaltrexone—Stinging—Bimatoprost—glaucoma	0.0069	0.0186	CcSEcCtD
Methylnaltrexone—Stinging—Brimonidine—glaucoma	0.00611	0.0165	CcSEcCtD
Methylnaltrexone—Stinging—Dorzolamide—glaucoma	0.00583	0.0157	CcSEcCtD
Methylnaltrexone—Erythema—Echothiophate—glaucoma	0.00579	0.0156	CcSEcCtD
Methylnaltrexone—Stinging—Pilocarpine—glaucoma	0.00551	0.0149	CcSEcCtD
Methylnaltrexone—Pain—Dipivefrin—glaucoma	0.00482	0.013	CcSEcCtD
Methylnaltrexone—Vomiting—Physostigmine—glaucoma	0.00421	0.0114	CcSEcCtD
Methylnaltrexone—Pain—Echothiophate—glaucoma	0.00404	0.0109	CcSEcCtD
Methylnaltrexone—Nausea—Physostigmine—glaucoma	0.00394	0.0106	CcSEcCtD
Methylnaltrexone—Flatulence—Carbachol—glaucoma	0.0034	0.00916	CcSEcCtD
Methylnaltrexone—Oedema—Metipranolol—glaucoma	0.00317	0.00854	CcSEcCtD
Methylnaltrexone—Erythema—Latanoprost—glaucoma	0.00315	0.00849	CcSEcCtD
Methylnaltrexone—Stinging—Timolol—glaucoma	0.00313	0.00844	CcSEcCtD
Methylnaltrexone—Oedema—Carteolol—glaucoma	0.00293	0.00791	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Carbachol—glaucoma	0.00272	0.00734	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.00266	0.00718	CcSEcCtD
Methylnaltrexone—Oedema—Latanoprost—glaucoma	0.00257	0.00693	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Latanoprost—glaucoma	0.00252	0.0068	CcSEcCtD
Methylnaltrexone—Erythema—Apraclonidine—glaucoma	0.00252	0.00679	CcSEcCtD
Methylnaltrexone—Skin disorder—Latanoprost—glaucoma	0.0025	0.00673	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00249	0.00671	CcSEcCtD
Methylnaltrexone—Erythema—Bimatoprost—glaucoma	0.00244	0.00658	CcSEcCtD
Methylnaltrexone—Pain—Carbachol—glaucoma	0.00241	0.00649	CcSEcCtD
Methylnaltrexone—Pain—Levobunolol—glaucoma	0.00237	0.00639	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Methazolamide—glaucoma	0.00229	0.00618	CcSEcCtD
Methylnaltrexone—Abdominal pain—Carbachol—glaucoma	0.00223	0.006	CcSEcCtD
Methylnaltrexone—Pain—Latanoprost—glaucoma	0.0022	0.00593	CcSEcCtD
Methylnaltrexone—Erythema—Brimonidine—glaucoma	0.00216	0.00583	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00213	0.00574	CcSEcCtD
Methylnaltrexone—Dizziness—Metipranolol—glaucoma	0.00209	0.00565	CcSEcCtD
Methylnaltrexone—Erythema—Dorzolamide—glaucoma	0.00207	0.00557	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00207	0.00557	CcSEcCtD
Methylnaltrexone—Erythema—Travoprost—glaucoma	0.00206	0.00554	CcSEcCtD
Methylnaltrexone—Oedema—Apraclonidine—glaucoma	0.00206	0.00554	CcSEcCtD
Methylnaltrexone—Erythema—Brinzolamide—glaucoma	0.00203	0.00547	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Apraclonidine—glaucoma	0.00202	0.00543	CcSEcCtD
Methylnaltrexone—Flatulence—Brinzolamide—glaucoma	0.002	0.00539	CcSEcCtD
Methylnaltrexone—Skin disorder—Apraclonidine—glaucoma	0.002	0.00538	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Bimatoprost—glaucoma	0.00195	0.00527	CcSEcCtD
Methylnaltrexone—Dizziness—Carteolol—glaucoma	0.00194	0.00523	CcSEcCtD
Methylnaltrexone—Skin disorder—Bimatoprost—glaucoma	0.00194	0.00522	CcSEcCtD
Methylnaltrexone—Diarrhoea—Carbachol—glaucoma	0.00193	0.00519	CcSEcCtD
Methylnaltrexone—Flatulence—Pilocarpine—glaucoma	0.00192	0.00518	CcSEcCtD
Methylnaltrexone—Dizziness—Diclofenamide—glaucoma	0.00191	0.00514	CcSEcCtD
Methylnaltrexone—Diarrhoea—Levobunolol—glaucoma	0.0019	0.00511	CcSEcCtD
Methylnaltrexone—Nausea—Metipranolol—glaucoma	0.00188	0.00507	CcSEcCtD
Methylnaltrexone—Dizziness—Carbachol—glaucoma	0.00186	0.00502	CcSEcCtD
Methylnaltrexone—Vomiting—Diclofenamide—glaucoma	0.00183	0.00494	CcSEcCtD
Methylnaltrexone—Dizziness—Levobunolol—glaucoma	0.00183	0.00494	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00183	0.00493	CcSEcCtD
Methylnaltrexone—Diarrhoea—Methazolamide—glaucoma	0.00182	0.0049	CcSEcCtD
Methylnaltrexone—Vomiting—Carbachol—glaucoma	0.00179	0.00483	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00177	0.00478	CcSEcCtD
Methylnaltrexone—Oedema—Brimonidine—glaucoma	0.00177	0.00476	CcSEcCtD
Methylnaltrexone—Pain—Apraclonidine—glaucoma	0.00176	0.00474	CcSEcCtD
Methylnaltrexone—Nausea—Carteolol—glaucoma	0.00174	0.0047	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00174	0.00469	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Brimonidine—glaucoma	0.00173	0.00467	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00172	0.00464	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00172	0.00463	CcSEcCtD
Methylnaltrexone—Skin disorder—Brimonidine—glaucoma	0.00171	0.00462	CcSEcCtD
Methylnaltrexone—Nausea—Diclofenamide—glaucoma	0.00171	0.00462	CcSEcCtD
Methylnaltrexone—Pain—Bimatoprost—glaucoma	0.0017	0.00459	CcSEcCtD
Methylnaltrexone—Dizziness—Latanoprost—glaucoma	0.0017	0.00458	CcSEcCtD
Methylnaltrexone—Vomiting—Methazolamide—glaucoma	0.00169	0.00455	CcSEcCtD
Methylnaltrexone—Oedema—Dorzolamide—glaucoma	0.00169	0.00454	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Apraclonidine—glaucoma	0.00168	0.00453	CcSEcCtD
Methylnaltrexone—Oedema—Travoprost—glaucoma	0.00168	0.00452	CcSEcCtD
Methylnaltrexone—Nausea—Carbachol—glaucoma	0.00167	0.00451	CcSEcCtD
Methylnaltrexone—Nausea—Levobunolol—glaucoma	0.00165	0.00444	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Travoprost—glaucoma	0.00165	0.00444	CcSEcCtD
Methylnaltrexone—Skin disorder—Travoprost—glaucoma	0.00163	0.00439	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Dorzolamide—glaucoma	0.00163	0.00439	CcSEcCtD
Methylnaltrexone—Abdominal pain—Apraclonidine—glaucoma	0.00163	0.00438	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Brinzolamide—glaucoma	0.00163	0.00438	CcSEcCtD
Methylnaltrexone—Skin disorder—Brinzolamide—glaucoma	0.00161	0.00434	CcSEcCtD
Methylnaltrexone—Oedema—Pilocarpine—glaucoma	0.00159	0.00429	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00159	0.00428	CcSEcCtD
Methylnaltrexone—Nausea—Methazolamide—glaucoma	0.00158	0.00425	CcSEcCtD
Methylnaltrexone—Erythema—Clonidine—glaucoma	0.00156	0.0042	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Pilocarpine—glaucoma	0.00154	0.00415	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Brimonidine—glaucoma	0.00152	0.00411	CcSEcCtD
Methylnaltrexone—Pain—Brimonidine—glaucoma	0.00151	0.00407	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Travoprost—glaucoma	0.00145	0.00391	CcSEcCtD
Methylnaltrexone—Pain—Dorzolamide—glaucoma	0.00144	0.00389	CcSEcCtD
Methylnaltrexone—Pain—Travoprost—glaucoma	0.00144	0.00387	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00143	0.00386	CcSEcCtD
Methylnaltrexone—Pain—Brinzolamide—glaucoma	0.00142	0.00382	CcSEcCtD
Methylnaltrexone—Diarrhoea—Apraclonidine—glaucoma	0.00141	0.00379	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Dorzolamide—glaucoma	0.00138	0.00372	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00138	0.00371	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Travoprost—glaucoma	0.00137	0.0037	CcSEcCtD
Methylnaltrexone—Pain—Pilocarpine—glaucoma	0.00136	0.00367	CcSEcCtD
Methylnaltrexone—Dizziness—Apraclonidine—glaucoma	0.00136	0.00366	CcSEcCtD
Methylnaltrexone—Erythema—Betaxolol—glaucoma	0.00136	0.00366	CcSEcCtD
Methylnaltrexone—Abdominal pain—Dorzolamide—glaucoma	0.00133	0.00359	CcSEcCtD
Methylnaltrexone—Abdominal pain—Travoprost—glaucoma	0.00133	0.00358	CcSEcCtD
Methylnaltrexone—Dizziness—Bimatoprost—glaucoma	0.00132	0.00355	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00132	0.00355	CcSEcCtD
Methylnaltrexone—Vomiting—Apraclonidine—glaucoma	0.00131	0.00352	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Pilocarpine—glaucoma	0.0013	0.00351	CcSEcCtD
Methylnaltrexone—Oedema—Clonidine—glaucoma	0.00127	0.00343	CcSEcCtD
Methylnaltrexone—Abdominal pain—Pilocarpine—glaucoma	0.00126	0.00339	CcSEcCtD
Methylnaltrexone—Diarrhoea—Acetazolamide—glaucoma	0.00126	0.00339	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Clonidine—glaucoma	0.00125	0.00336	CcSEcCtD
Methylnaltrexone—Skin disorder—Clonidine—glaucoma	0.00124	0.00333	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Clonidine—glaucoma	0.00123	0.00331	CcSEcCtD
Methylnaltrexone—Nausea—Apraclonidine—glaucoma	0.00122	0.00329	CcSEcCtD
Methylnaltrexone—Dizziness—Acetazolamide—glaucoma	0.00122	0.00328	CcSEcCtD
Methylnaltrexone—Nausea—Bimatoprost—glaucoma	0.00118	0.00319	CcSEcCtD
Methylnaltrexone—Vomiting—Acetazolamide—glaucoma	0.00117	0.00315	CcSEcCtD
Methylnaltrexone—Dizziness—Brimonidine—glaucoma	0.00117	0.00315	CcSEcCtD
Methylnaltrexone—Diarrhoea—Dorzolamide—glaucoma	0.00115	0.00311	CcSEcCtD
Methylnaltrexone—Diarrhoea—Travoprost—glaucoma	0.00115	0.0031	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00115	0.00309	CcSEcCtD
Methylnaltrexone—Diarrhoea—Brinzolamide—glaucoma	0.00113	0.00306	CcSEcCtD
Methylnaltrexone—Dizziness—Dorzolamide—glaucoma	0.00111	0.003	CcSEcCtD
Methylnaltrexone—Dizziness—Travoprost—glaucoma	0.00111	0.00299	CcSEcCtD
Methylnaltrexone—Erythema—Timolol—glaucoma	0.00111	0.00299	CcSEcCtD
Methylnaltrexone—Oedema—Betaxolol—glaucoma	0.00111	0.00298	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Clonidine—glaucoma	0.0011	0.00296	CcSEcCtD
Methylnaltrexone—Dizziness—Brinzolamide—glaucoma	0.0011	0.00295	CcSEcCtD
Methylnaltrexone—Nausea—Acetazolamide—glaucoma	0.00109	0.00294	CcSEcCtD
Methylnaltrexone—Diarrhoea—Pilocarpine—glaucoma	0.00109	0.00294	CcSEcCtD
Methylnaltrexone—Pain—Clonidine—glaucoma	0.00109	0.00293	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Betaxolol—glaucoma	0.00109	0.00293	CcSEcCtD
Methylnaltrexone—Skin disorder—Betaxolol—glaucoma	0.00108	0.0029	CcSEcCtD
Methylnaltrexone—Vomiting—Dorzolamide—glaucoma	0.00107	0.00289	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Betaxolol—glaucoma	0.00107	0.00289	CcSEcCtD
Methylnaltrexone—Vomiting—Brinzolamide—glaucoma	0.00105	0.00284	CcSEcCtD
Methylnaltrexone—Dizziness—Pilocarpine—glaucoma	0.00105	0.00284	CcSEcCtD
Methylnaltrexone—Nausea—Brimonidine—glaucoma	0.00105	0.00283	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Clonidine—glaucoma	0.00104	0.0028	CcSEcCtD
Methylnaltrexone—Vomiting—Pilocarpine—glaucoma	0.00101	0.00273	CcSEcCtD
Methylnaltrexone—Abdominal pain—Clonidine—glaucoma	0.00101	0.00271	CcSEcCtD
Methylnaltrexone—Nausea—Dorzolamide—glaucoma	0.001	0.0027	CcSEcCtD
Methylnaltrexone—Nausea—Travoprost—glaucoma	0.000997	0.00269	CcSEcCtD
Methylnaltrexone—Nausea—Brinzolamide—glaucoma	0.000984	0.00265	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Betaxolol—glaucoma	0.000956	0.00258	CcSEcCtD
Methylnaltrexone—Pain—Betaxolol—glaucoma	0.000947	0.00255	CcSEcCtD
Methylnaltrexone—Nausea—Pilocarpine—glaucoma	0.000946	0.00255	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000937	0.00253	CcSEcCtD
Methylnaltrexone—Oedema—Timolol—glaucoma	0.000905	0.00244	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Timolol—glaucoma	0.000887	0.00239	CcSEcCtD
Methylnaltrexone—Skin disorder—Timolol—glaucoma	0.000879	0.00237	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Timolol—glaucoma	0.000875	0.00236	CcSEcCtD
Methylnaltrexone—Diarrhoea—Clonidine—glaucoma	0.00087	0.00235	CcSEcCtD
Methylnaltrexone—Dizziness—Clonidine—glaucoma	0.000841	0.00227	CcSEcCtD
Methylnaltrexone—Vomiting—Clonidine—glaucoma	0.000809	0.00218	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Timolol—glaucoma	0.000781	0.00211	CcSEcCtD
Methylnaltrexone—Pain—Timolol—glaucoma	0.000774	0.00209	CcSEcCtD
Methylnaltrexone—Diarrhoea—Betaxolol—glaucoma	0.000758	0.00204	CcSEcCtD
Methylnaltrexone—Nausea—Clonidine—glaucoma	0.000756	0.00204	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Timolol—glaucoma	0.00074	0.00199	CcSEcCtD
Methylnaltrexone—Dizziness—Betaxolol—glaucoma	0.000732	0.00197	CcSEcCtD
Methylnaltrexone—Abdominal pain—Timolol—glaucoma	0.000715	0.00193	CcSEcCtD
Methylnaltrexone—Vomiting—Betaxolol—glaucoma	0.000704	0.0019	CcSEcCtD
Methylnaltrexone—Nausea—Betaxolol—glaucoma	0.000658	0.00177	CcSEcCtD
Methylnaltrexone—Diarrhoea—Timolol—glaucoma	0.000619	0.00167	CcSEcCtD
Methylnaltrexone—Dizziness—Timolol—glaucoma	0.000598	0.00161	CcSEcCtD
Methylnaltrexone—Vomiting—Timolol—glaucoma	0.000575	0.00155	CcSEcCtD
Methylnaltrexone—Nausea—Timolol—glaucoma	0.000537	0.00145	CcSEcCtD
